Instil Bio, Inc. Marketable Securities (Current)
Instil Bio, Inc. (TIL) had Marketable Securities (Current) of $141.16 million as of 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:MarketableSecuritiesCurrent · last filed 2024-03-21
- 2023-12-31: Marketable Securities, Current $141.16M.
- 2023-09-30: Marketable Securities, Current $174.31M.
- 2023-06-30: Marketable Securities, Current $179.94M.
- 2023-03-31: Marketable Securities, Current $195.84M.
| Period end | Marketable Securities, Current |
|---|---|
| 2023-12-31 | $141.16M 10-K · filed 2024-03-21 |
| 2023-09-30 | $174.31M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $179.94M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $195.84M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $217.20M 10-K · filed 2024-03-21 |
| 2022-09-30 | $262.17M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $312.14M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $318.05M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $416.51M 10-K · filed 2023-03-31 |
| 2021-09-30 | $494.96M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |